Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMPE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,664
Award facts
- Contract value 100% obligated
- $45,664.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $45,664.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a standalone purchase under DMS Pharmaceutical Group's broader prime vendor contract with DLA. The award carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will supply pharmaceutical products and medical consumables to support Department of Defense healthcare operations, leveraging its established position within the federal pharmaceutical supply chain.
This delivery order falls under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical support to military healthcare facilities worldwide. The underlying IDC, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and medical consumables. DMS Pharmaceutical Group's established track record supplying specialized pharmaceutical products—including oncology treatments, immunosuppressants, biologics, and emergency medications—positions the company as a critical supplier within the Department of Defense's global medical supply chain.
Quick answers
Who was awarded contract SPE2DU26FEMPE?
SPE2DU26FEMPE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DU26FEMPE worth?
The government has obligated $45,664 on SPE2DU26FEMPE.
Is contract SPE2DU26FEMPE an order under another contract?
Yes. SPE2DU26FEMPE is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMPE competed?
The extent of competition for SPE2DU26FEMPE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award